Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Biotechnology and Pharmaceutical Executives from New England's Top Companies to Attend the Second Annual Convergence - The Life Sciences Leaders Forum.


MARTHA'S VINEYARD Martha's Vineyard (vĭn`yərd), island (1990 est. pop. 8,900), c.100 sq mi (260 sq km), SE Mass., separated from the Elizabeth Islands and Cape Cod by Vineyard and Nantucket sounds. , Mass. -- Second Annual Convergence convergence

Mathematical property of infinite series, integrals on unbounded regions, and certain sequences of numbers. An infinite series is convergent if the sum of its terms is finite.
 - The Life Sciences Leaders Forum
WHO:   Speakers for the event include, but are not limited
       to the following executives:

       --  John Abele, PhD, Dir., Founder & Chairman - Boston
           Scientific Corporation
       --  Noubar Afeyan, PhD, Managing Partner - Flagship Ventures
       --  Joseph Bolen, PhD, Senior VP of Discovery Research -
           Millennium Pharmaceuticals
       --  Lee Brettman, MD, FACP, President, CEO and Director -
           Dynogen Pharmaceuticals, Inc.
       --  Maggie Flanagan, PhD, Global Alliance Director for Global
           Sciences and Information - AstraZeneca Pharmaceuticals
       --  Jeff Elton, PhD, SVP of Strategy and COO - Novartis
           Institutes for Biomedical Research
       --  Wendy Everett, ScD, President - New England Healthcare
           Institute
       --  Thomas Finneran, President - Massachusetts Biotech Council
       --  Jean-Francois Formela, MD, Senior Partner - Atlas Venture
       --  Michael Gilman, PhD, Executive VP of R&D - Biogen Idec
       --  Robert Gould, PhD, VP, Licensing and External Research -
           Merck Research Labs Boston
       --  Sylvie Gregoire, CEO - GlycoFi
       --  Steven Holtzman, President and CEO - Infinity
           Pharmaceuticals, Inc.
       --  Glenn Larsen, PhD, CSO - Hydra Biosciences
       --  John Maraganore, PhD, CEO - Alnylam Pharmaceuticals
       --  Bennett Shapiro, PhD, Former Executive VP of Worldwide
           Licensing - Merck & Co.; Director - PureTech Ventures
       --  Jean-Pierre Sommadossi, PhD, CEO - Idenix Pharmaceuticals
           Inc.

WHAT:  Convergence - The Life Sciences Leaders Forum
       (www.convergenceforum.com) will bring together high-level
       life sciences players to discuss and debate the most
       pressing topics of interest to the industry - topics like
       forging strong corporate partnerships; attracting funding
       from private and public sources; building successful
       research organizations; streamlining product development
       and approval; understanding the coming convergence of
       biology, software, and medical devices; and staying ahead
       of regulatory changes.

WHEN & WHERE
June 9-11, 2005
Mansion House
9 Main Street
Vineyard Haven on Martha's Vineyard
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Apr 12, 2005
Words:259
Previous Article:DiskSites and Macnica Networks Sign Strategic Alliance; Alliance Allows Macnica Networks to Market and Deploy DiskSites' WAFS Solutions in Japan.
Next Article:Take-Two Interactive Software, Inc. Completes 3 for 2 Stock Split.



Related Articles
California's Largest Annual BioScience Industry Conference to Kick Off All New Format Detailing the ``Science of Success''.
GVA launches new Life Sciences Group.
Frost & Sullivan's 7th Annual Marketing Innovations in the Pharmaceutical Industry 2003 Executive Summit Announced.
BioTech Today Radio to Air Special Pharmaceutical Marketing Congress Broadcast on September 21, 5:00 P.M. ET.
Wood Mackenzie: 50 Percent of the Top 10 Pharmaceutical Companies Have Stale Pipelines by 2008.
Massachusetts Governor Mitt Romney to Deliver Keynote Address at the Seventh Annual MASS Opportunities Biotechnology Investment Conference.
New journals from American Scientific Publishers.
MBC Annual Meeting, Building the Global Pipeline: Massachusetts Life Sciences at Work, Will be Held June 15; Panels to Highlight Financing, Science...
MIT Biomedical Innovation Forum to Address the Future of Vaccines and Central Nervous System Disorders Through the Lens of Personalized Medicine.
MBC's 8th Annual MASS Opportunities Conference to Feature Presentations Roundtables, and Panels with Over 50 Companies and Industry Leaders.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles